The Freudenberg Group is a global company with a 177-year history, originally founded as a tanning business. Over time, it has diversified into multiple sectors, including automotive, chemicals, medical devices, specialty materials and more. In FY2025, the group reported €11.73 billion in sales and €1.09 billion in operating profit, reflecting slight declines due to currency effects and lower volumes. Despite these challenges, the company remains financially strong, with a 57.1% equity ratio and a solid long-term strategy focused on stability, innovation, and future growth.
Freudenberg continues to invest heavily in research and development, with €579.5 million spent in FY2025 (4.9% of sales). Focus areas include AI, digitalization and new technologies, with a dedicated €200 million planned for AI-driven research by 2028.
Freudenberg in India: Rapid Expansion and Strategic Focus
Freudenberg’s association with India began in the leather segment, reflecting its original business roots. Over the past two and a half decades, its presence in India has grown significantly. Today, India is a key growth market, generating ₹4,427 crore in sales with healthy double-digit profits.
The company has established multiple manufacturing plants in Pune, Mysore, Chennai and Chandigarh, each focused on specific segments and producing components tailored to their respective industries. Freudenberg emphasises local production for local consumption, with exports forming a smaller share (estimated at 5–10%) of total output.
Key Sectors and Activities in India
- Chemicals and Specialty Lubricants
Freudenberg has a strong focus on specialty lubricants designed for demanding applications such as high-temperature furnaces and high-speed industrial machinery operating at around 15,000 rpm.
For energy-related applications, most technologies are developed in Europe and introduced into India, as the country currently lacks large-scale commercial capacity in this domain. - Medical Devices and Medical Technology
The medical devices segment is relatively new in India, established 3–4 years ago. Freudenberg collaborates with the Shriram Institute of Technology and pharmaceutical manufacturers, particularly for the export of transdermal patches. While still niche, the company is involved in manufacturing catheters, base materials for drug delivery and filtration technologies. - Strategic Growth and Acquisitions
Freudenberg actively explores acquisitions in India as part of its growth strategy and does not hesitate to pursue opportunities that strengthen its local presence.
Outlook
Despite global volatility, Freudenberg maintains a strong balance sheet, continues to invest in innovation and focuses on AI and digitalization for future growth. With rapid expansion in India and a commitment to local manufacturing, the company is positioned to strengthen its presence across chemicals, medical devices and specialty materials.
